People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Iliad Biotechnologies, Llc | — | Biotechnology | Series C | $98.3M | $52.0M | 2018 |
| Callidus Biopharma, Inc. | — | Pharmaceuticals | Series A | $11.3M | $142.8M | 2012 |
| Seneca Therapeutics, Inc. | — | Pharmaceuticals | Series A | $11.0M | $6.9M | 2024 |
| Biovie Inc. | — | Biotechnology | Series A | $10.5M | $81.1M | 2017 |
Cuong Do at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cuong Do on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard J. Berman | 1 | 8 |
| David Johnston | 1 | 8 |
| Jonathan Adams | 1 | 7 |
| Avi Naider | 1 | 6 |
| MICHAEL SHERMAN | 1 | 5 |
| Mina Sooch | 1 | 5 |
| Terren Peizer | 1 | 4 |
| Terren S. Peizer | 1 | 4 |
| Steve J. Gorlin | 1 | 3 |
| Hari Kumar | 1 | 3 |
| Eric Edidin | 1 | 3 |
| Julie Anderson | 1 | 3 |
| Rajah Menon | 1 | 2 |
| James Hussey | 1 | 2 |
| James Lang | 1 | 2 |
| KEITH RUBIN | 1 | 2 |
| Michael S. Sherman | 1 | 2 |
| Penelope Markham | 1 | 1 |
| Elliot Ehrlich | 1 | 1 |
| KEN SOLOVAY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.